- Home
- PTGX vs EEFT Comparison
PTGX vs EEFT Comparison
Compare PTGX & EEFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PTGX | EEFT |
|---|---|---|
| Founded | 2006 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 3.0B |
| IPO Year | 2016 | 1997 |
Fundamental Metrics
Financial Performance| Metric | PTGX | EEFT |
|---|---|---|
| Price | $89.29 | $74.89 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 5 |
| Target Price | $86.44 | ★ $117.60 |
| AVG Volume (30 Days) | ★ 898.7K | 839.8K |
| Earning Date | 11-06-2025 | 10-22-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.72 | ★ 6.78 |
| Revenue | $209,217,000.00 | ★ $4,182,800,000.00 |
| Revenue This Year | N/A | $9.05 |
| Revenue Next Year | $296.47 | $7.63 |
| P/E Ratio | $124.48 | ★ $11.03 |
| Revenue Growth | N/A | ★ 7.25 |
| 52 Week Low | $33.70 | $68.56 |
| 52 Week High | $93.25 | $114.25 |
Technical Indicators
Market Signals| Indicator | PTGX | EEFT |
|---|---|---|
| Relative Strength Index (RSI) | 64.67 | 49.65 |
| Support Level | $83.52 | $73.22 |
| Resistance Level | $90.85 | $75.66 |
| Average True Range (ATR) | 2.63 | 1.88 |
| MACD | -0.33 | 0.87 |
| Stochastic Oscillator | 83.62 | 80.43 |
Price Performance
Historical ComparisonAbout PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About EEFT Euronet Worldwide Inc.
Euronet Worldwide Inc is a provider of electronic financial transaction solutions. It offers payment and transaction processing and distribution solutions to financial institutions, retailers, service providers, and individual consumers. The company's product offerings include comprehensive ATM, POS, card outsourcing, card issuing and merchant acquiring services, software solutions, money transfer services, etc. Its reportable operating segments are EFT Processing, epay, and Money Transfer. Maximum revenue is derived from its Money Transfer segment, which provides money transfer services across the world under the brand names Ria, AFEX, IME, and xe. Geographically, the company generates maximum revenue from the United States, followed by Germany, India, France, Greece, and other regions.